Science Explorer Back to mapMap
Discussion
Hospital / health system · Nagoya · Japan

Aichi Cancer Center

In research, Aichi Cancer Center stands highest in Health Sciences (#1,916 of 9,902 worldwide), Medicine (#2,009 of 8,541 worldwide) and Surgery (#737 of 1,532 worldwide), 2022-now. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Cancer Research (Oncology is 16.7× its share of world research).

pref.aichi.jp/cancer-center/english/ccROR OpenAlex
World rank, 2022-now
#8,450
of 22,385 · #9,785 all time
Rank in Japan
#195
of 924
Research works
4.8k
▼ 8% vs 2018-21
Citations
137k
28.3 per fractional work
Top-10% rate
9.3%
all institutions 10.0%
vs its own fields
0.99×
1.00× is exactly expected
Open access
39%
world 40%
International
11%
world 18%
Aichi Cancer Center

What is Aichi Cancer Center known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #1,916 of 9,902 9.7%398 #2887
MedicineField #2,009 of 8,541 9.7%389 #2787
SurgerySubfield #737 of 1,532 10.3%78 #1460
Pulmonary and Respiratory MedicineSubfield #536 of 1,037 12.0%97 #857
OncologySubfield #464 of 755 7.5%91 #688
Life SciencesDomain #4,391 of 6,403 9.6%68 #5554

Each strip is that field's whole ranked pool, with the notch where Aichi Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#2,887 #1,916
  2. Medicine#2,787 #2,009
  3. Surgery#1,460 #737
  4. Pulmonary and Respiratory Medicine#857 #536
  5. Oncology#688 #464
  6. Life Sciences#5,554 #4,391
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does Aichi Cancer Center work in?

In 2022-now, 81% of research at Aichi Cancer Center is in Health Sciences, 14% in Life Sciences. Its largest fields are Medicine (80%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (2%). It does 3.5× the world's share of Health Sciences.

Health Sciences: 453 fractional works · 81.2% of its workMedicine: 444 fractional works · 79.6% of its workPulmonary and Respiratory Medicine: 110 fractional works · 19.8% of its workOncology: 105 fractional works · 18.7% of its workSurgery: 92 fractional works · 16.5% of its workPathology and Forensic Medicine: 17 fractional works · 3.1% of its workRadiology, Nuclear Medicine and Imaging: 16 fractional works · 2.9% of its workEpidemiology: 13 fractional works · 2.4% of its workOtorhinolaryngology: 12 fractional works · 2.2% of its workGastroenterology: 10 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 8 fractional works · 1.4% of its workPhysiology: 7 fractional works · 1.2% of its workHepatology: 7 fractional works · 1.2% of its workGenetics: 6 fractional works · 1.1% of its workNeurology: 4 fractional works · 0.8% of its workObstetrics and Gynecology: 4 fractional works · 0.8% of its workHematology: 3 fractional works · 0.6% of its workDermatology: 3 fractional works · 0.6% of its workRheumatology: 3 fractional works · 0.6% of its workReproductive Medicine: 3 fractional works · 0.5% of its workInfectious Diseases: 3 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 0.4% of its workPsychiatry and Mental health: 2 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 0.4% of its workNephrology: 2 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.2% of its workOphthalmology: 1 fractional works · 0.2% of its workSmaller subfields together: 6 fractional works · 1.1% of its workHealth Professions: 5 fractional works · 0.9% of its workSpeech and Hearing: 2 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.5% of its workDentistry: 2 fractional works · 0.4% of its workNursing: 1 fractional works · 0.2% of its workNutrition and Dietetics: 1 fractional works · 0.2% of its workVeterinary: 1 fractional works · 0.2% of its workLife Sciences: 78 fractional works · 13.9% of its workBiochemistry, Genetics and Molecular Biology: 64 fractional works · 11.6% of its workMolecular Biology: 28 fractional works · 4.9% of its workCancer Research: 21 fractional works · 3.8% of its workGenetics: 6 fractional works · 1.1% of its workCell Biology: 4 fractional works · 0.7% of its workBiotechnology: 2 fractional works · 0.4% of its workEndocrinology: 1 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.3% of its workImmunology and Microbiology: 9 fractional works · 1.7% of its workImmunology: 8 fractional works · 1.5% of its workSmaller subfields together: 1 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.1% of its workPhysical Sciences: 21 fractional works · 3.8% of its workPhysics and Astronomy: 8 fractional works · 1.4% of its workRadiation: 8 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 6 fractional works · 1.1% of its workComputer Vision and Pattern Recognition: 4 fractional works · 0.7% of its workArtificial Intelligence: 2 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.1% of its workEngineering: 5 fractional works · 1.0% of its workBiomedical Engineering: 4 fractional works · 0.7% of its workSmaller subfields together: 1 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.0% of its workSocial Sciences: 6 fractional works · 1.1% of its workEconomics, Econometrics and Finance: 4 fractional works · 0.7% of its workEconomics and Econometrics: 4 fractional works · 0.7% of its workSocial Sciences: 1 fractional works · 0.3% of its workPsychology: 1 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.0% of its workALL ITS WORKAichi CancerCenter558fractional works, 2022-now
Life Sciences14%Physical Sciences4%Health Sciences81%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine44479.6%
    2. Health Professions50.9%
    3. Dentistry20.4%
    4. Nursing10.2%
    5. Veterinary10.2%
    1. Biochemistry, Genetics and Molecular Biology6411.6%
    2. Immunology and Microbiology91.7%
    3. Neuroscience20.4%
    4. Pharmacology, Toxicology and Pharmaceutics10.2%
    5. Agricultural and Biological Sciences10.1%
    1. Physics and Astronomy81.4%
    2. Computer Science61.1%
    3. Engineering51.0%
    4. Environmental Science10.2%
    5. Chemistry00.1%
    6. Mathematics00.1%
    7. Materials Science00.0%
    1. Economics, Econometrics and Finance40.7%
    2. Social Sciences10.3%
    3. Psychology10.2%
    4. Arts and Humanities00.0%
    5. Business, Management and Accounting00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Aichi Cancer Center specialise in?

Where its research is concentrated relative to its size: Oncology takes 16.7× the share of its output that it takes of world research.

  1. OncologySubfield · 104.5 works17×
  2. Pulmonary and Respiratory MedicineSubfield · 110.2 works13×
  3. Cancer ResearchSubfield · 21.2 works8.8×
  4. SurgerySubfield · 92.0 works7.0×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.17× its world share, 64 worksBiochemistry, Geneti…Immunology and Microbiology: 1.65× its world share, 9 worksImmunology and Micro…Neuroscience: 0.26× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.44× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.05× its world share, 0 worksChemistryComputer Science: 0.14× its world share, 6 worksComputer ScienceEngineering: 0.07× its world share, 6 worksEngineeringEnvironmental Science: 0.03× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.01× its world share, 0 worksMaterials ScienceMathematics: 0.06× its world share, 0 worksMathematicsPhysics and Astronomy: 0.63× its world share, 8 worksPhysics and AstronomyDentistry: 0.76× its world share, 2 worksDentistryHealth Professions: 0.33× its world share, 5 worksHealth ProfessionsMedicine: 4.14× its world share, 444 worksMedicineNursing: 0.42× its world share, 1 worksNursingVeterinary: 1.25× its world share, 1 worksVeterinaryArts and Humanities: 0.01× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.31× its world share, 4 worksEconomics, Econometr…Psychology: 0.06× its world share, 1 worksPsychologySocial Sciences: 0.02× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.

All 21 fields, with their numbers
  1. Medicine4.14×444 works
  2. Biochemistry, Genetics and Molecular Biology2.17×64 works
  3. Immunology and Microbiology1.65×9 works
  4. Veterinary1.25×1 works
  5. Dentistry0.76×2 works
  6. Physics and Astronomy0.63×8 works
  7. Pharmacology, Toxicology and Pharmaceutics0.44×1 works
  8. Nursing0.42×1 works
  9. Health Professions0.33×5 works
  10. Economics, Econometrics and Finance0.31×4 works
  11. Neuroscience0.26×2 works
  12. Computer Science0.14×6 works
  13. Engineering0.07×6 works
  14. Mathematics0.06×0 works
  15. Psychology0.06×1 works
  16. Chemistry0.05×0 works
  17. Agricultural and Biological Sciences0.03×1 works
  18. Environmental Science0.03×1 works
  19. Social Sciences0.02×2 works
  20. Materials Science0.01×0 works
  21. Arts and Humanities0.01×0 works

Who are the top researchers at Aichi Cancer Center?

Ranked on the quality score, Hiromichi Ebi, Hiroji Iwata and Keitaro Matsuo lead among researchers whose main affiliation is Aichi Cancer Center.

  1. 1 Hiromichi Ebi Japan · #82,988 worldwide 8.9k citations · 239 works
  2. 2 Hiroji Iwata Japan · #121,825 worldwide 57k citations · 850 works
  3. 3 Keitaro Matsuo Japan · #158,749 worldwide 55k citations · 1,426 works
  4. 4 Yoshitaka Sekido Japan · #169,704 worldwide 19k citations · 446 works
  5. 5 Toyoaki Hida Japan · #196,252 worldwide 29k citations · 449 works
  6. 6 Yasushi Yatabe Japan · #211,823 worldwide 73k citations · 1,227 works
  7. 7 Hidemi M. Ito Japan · #297,980 worldwide 26k citations · 542 works
  8. 8 Masaki Inagaki Japan · #303,625 worldwide 23k citations · 321 works
  9. 9 Masahiro Aoki Japan · #442,761 worldwide 6.3k citations · 122 works
  10. 10 Waki Hosoda Japan · #450,807 worldwide 3.7k citations · 168 works
All ranked researchers at Aichi Cancer Center

What are the most cited papers from Aichi Cancer Center?

The most cited paper from Aichi Cancer Center is "Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial" (Yung‐Jue Bang, Eric Van Cutsem, Andrea Feyereislova et al., 2010), with 7,405 citations. Next come "Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer" (5,138) and "International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma" (4,890).

Most cited papers
#PaperReleasedCitations
1 Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Yung‐Jue Bang, Eric Van Cutsem, Andrea Feyereislova et al. · The Lancet Open access Aug 2010 7,405
2 Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Martine J Piccart et al. · New England Journal of Medicine Open access 20 Oct 2005 5,138
3 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma William David Travis et al. · Journal of Thoracic Oncology Open access 20 Jan 2011 4,890
4 Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial Achim Rittmeyer et al. · The Lancet Open access 12 Dec 2016 4,817
5 The 2015 World Health Organization Classification of Lung Tumors William David Travis, Elisabeth M. Brambilla, Andrew Gordon Nicholson et al. · Journal of Thoracic Oncology Open access 21 Aug 2015 4,651
All 60 most cited papers, with filters and sorting

Which keywords describe research at Aichi Cancer Center?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Neoadjuvant Therapy, Clinical Practice Guidelines, Immunotherapy, Radiotherapy, Prognostic Factors, Survival Analysis and Tumor Microenvironment.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy120▲ 30×23 topics
  2. Neoadjuvant Therapy52▲ 39×5 topics
  3. Clinical Practice Guidelines52▲ 17×13 topics
  4. Immunotherapy51▲ 13×18 topics
  5. Radiotherapy46▲ 21×12 topics
  6. Epidemiology46▲ 2.0×68 topics
  7. Prognostic Factors42▲ 17×14 topics
  8. Survival Analysis40▲ 26×6 topics
  9. Tumor Microenvironment39▲ 15×7 topics
  10. Endoscopic Resection37▲ 68×2 topics
  11. Molecular Characterization35▲ 35×6 topics
  12. Adjuvant Therapy35▲ 50×2 topics
  13. Targeted Therapy34▲ 28×4 topics
  14. Breast Cancer28▲ 20×10 topics
  15. Clinical Trials27▲ 7.3×11 topics
  16. Gastric Cancer27▲ 44×3 topics
  17. Surgical Management26▲ 12×13 topics
  18. Quality of Life25▲ 3.1×22 topics
  19. Cetuximab24▲ 52×2 topics
  20. Neoadjuvant Chemotherapy24▲ 52×2 topics
  21. Lymph Node Dissection24▲ 74×1 topic
  22. Metastatic Gastric Cancer24▲ 74×1 topic
  23. Cancer24▲ 3.1×41 topics
  24. Preoperative Chemoradiotherapy23▲ 51×2 topics
  25. Chemoradiation20▲ 55×2 topics
  26. Cholangiocarcinoma20▲ 44×2 topics
  27. Molecular Subtypes19▲ 40×3 topics
  28. Precision Medicine19▲ 6.9×7 topics
  29. Pancreatic Cancer19▲ 32×2 topics
  30. Gemcitabine19▲ 48×1 topic
  31. Surgery19▲ 9.7×9 topics
  32. Surgical Complications19▲ 42×1 topic
  33. Metastasis18▲ 9.4×12 topics
  34. Survival18▲ 22×4 topics
  35. Prognosis17▲ 9.3×7 topics
  36. Tumor Markers17▲ 36×2 topics
  37. PET Imaging17▲ 18×4 topics
  38. Treatment Guidelines16▲ 14×5 topics
  39. Genomic Profiling16▲ 27×2 topics
  40. ALK Inhibitors15▲ 44×1 topic

Which research topics does Aichi Cancer Center publish most on?

By volume in 2022-now: Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research, Lung Cancer Treatments and Mutations and Esophageal Cancer Research and Treatment.

Gastric Cancer Managemen…24Gastric Cancer Management and Outcomes: 24 fractional worksPancreatic and Hepatic O…19Pancreatic and Hepatic Oncology Research: 19 fractional worksLung Cancer Treatments and Mutations: 15 fractional worksEsophageal Cancer Research and Treatment: 14 fractional worksGallbladder and Bile Duct Disorders: 13 fractional worksCancer Immunotherapy and Biomarkers: 13 fractional worksColorectal Cancer Treatm…12Colorectal Cancer Treatments and Studies: 12 fractional worksHead and Neck Cancer Studies: 12 fractional worksLung Cancer Diagnosis and Treatment: 11 fractional worksCancer Genomics and Diag…10Cancer Genomics and Diagnostics: 10 fractional works
Pulmonary and Respiratory MedicineOncologySurgeryOtorhinolaryngology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 24 works
  2. 2 Pancreatic and Hepatic Oncology Research Oncology 19 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 15 works
  4. 4 Esophageal Cancer Research and Treatment Surgery 14 works
  5. 5 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 13 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 13 works
  7. 7 Colorectal Cancer Treatments and Studies Oncology 12 works
  8. 8 Head and Neck Cancer Studies Otorhinolaryngology 12 works
  9. 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 11 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 10 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.1%not open60.9%

World: 40% of research is openly available.

with international co-authors10.7%domestic only89.3%

World: 18% is written across borders.

How has Aichi Cancer Center's research output changed?

Output in 2022-2025 was 8% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Aichi Cancer Center as a percentage of every work published that year, 0.0022% in 2024.

still counting0.010%0.020%Aichi Cancer Center0.0018% in 202519801990200020102020

Fractional works of Aichi Cancer Center over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%Aichi Cancer Center10.5% in 2025all institutions10.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.0% in 2009.

Other research institutions in Nagoya

All research institutions in Nagoya

Share Aichi Cancer Center's ranking

Aichi Cancer Center on Science Explorer

A card with Aichi Cancer Center's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Aichi Cancer Center. Posts are plain text and can be reported.